Singapore markets closed
Straits Times Index
3,110.73 +36.47 (+1.19%) Nikkei
32,307.86 -550.45 (-1.68%) Hang Seng
16,334.37 -11.52 (-0.07%) FTSE 100
7,543.45 +29.73 (+0.40%) Bitcoin USD
43,670.83 +388.47 (+0.90%) CMC Crypto 200
901.74 +9.02 (+1.01%)
SpringWorks Therapeutics, Inc. (SWTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 1.91B |
| Enterprise value | 1.49B |
| Trailing P/E | 21.09 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 4.83 |
| Enterprise value/revenue | 64.18 |
| Enterprise value/EBITDA | -4.64 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.78 |
| 52-week change 3 | 27.14% |
| S&P500 52-week change 3 | 16.55% |
| 52-week high 3 | 34.16 |
| 52-week low 3 | 18.00 |
| 50-day moving average 3 | 23.56 |
| 200-day moving average 3 | 26.31 |
Share statistics
| Avg vol (3-month) 3 | 984.65k |
| Avg vol (10-day) 3 | 2.78M |
| Shares outstanding 5 | 62.58M |
| Implied shares outstanding 6 | 62.58M |
| Float 8 | 46.39M |
| % held by insiders 1 | 6.61% |
| % held by institutions 1 | 110.34% |
| Shares short (14 Nov 2023) 4 | 9.87M |
| Short ratio (14 Nov 2023) 4 | 14.23 |
| Short % of float (14 Nov 2023) 4 | 19.19% |
| Short % of shares outstanding (14 Nov 2023) 4 | 15.78% |
| Shares short (prior month 12 Oct 2023) 4 | 10.39M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Sept 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -35.13% |
| Return on equity (ttm) | -60.55% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -321.62M |
| Net income avi to common (ttm) | -304.96M |
| Diluted EPS (ttm) | -4.87 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 422.42M |
| Total cash per share (mrq) | 6.76 |
| Total debt (mrq) | 7.33M |
| Total debt/equity (mrq) | 1.86% |
| Current ratio (mrq) | 8.60 |
| Book value per share (mrq) | 6.32 |
Cash flow statement
| Operating cash flow (ttm) | -214.29M |
| Levered free cash flow (ttm) | -127.8M |
© 2023 Yahoo. All rights reserved.